EDUARDO
DÍAZ-RUBIO GARCÍA
Investigador hasta 2020
University of Glasgow
Glasgow, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Glasgow (4)
2012
2008
-
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 26, Núm. 12, pp. 2006-2012
2006
-
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: The X-ACT trial
British Journal of Cancer, Vol. 94, Núm. 8, pp. 1122-1129
2004
-
XELOX (capecitabine plus oxaliplatin): Active first-line therapy for patients with metastatic colorectal cancer
Journal of Clinical Oncology, Vol. 22, Núm. 11, pp. 2084-2091